Copy	B:C1511518
number	I:C1511518
variation	I:C1511518
of	O
FCGR	O
genes	I:C0017337
in	O
etiopathogenesis	O
of	O
sarcoidosis	O

Copy	O
number	I:C1511518
variation	I:C1511518
of	O
FCGR	B:C0017337
genes	I:C0017337
in	O
etiopathogenesis	O
of	O
sarcoidosis	O

Copy	O
number	I:C1511518
variation	I:C1511518
of	O
FCGR	O
genes	I:C0017337
in	O
etiopathogenesis	O
of	O
sarcoidosis	B:C0036202

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	B:C1414554
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	O
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	B:C1414556
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	O
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	B:C1414553
,	O
FCGR2C	O
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	B:C1521989
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	O
and	O
FCGR3A	B:C1414555
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	O
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	B:C0034805
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	O
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	B:C0034805
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	O
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	B:C0003313
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	O
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	B:C0026926
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	O
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	B:C0018850
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	O
.	O

We	O
have	O
previously	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
polymorphism	O
of	O
FCGR2B	O
and	O
FCGR3B	O
,	O
polymorphism	O
of	O
FCGR2A	O
,	O
FCGR2C	O
and	O
FCGR3A	O
genes	I:C1414555
,	O
encoding	O
receptors	O
for	I:C0034805
Fc	I:C0034805
fragment	I:C0034805
of	I:C0034805
immunoglobulin	I:C0034805
G	I:C0034805
(	O
Fcγ	O
receptors	I:C0034805
)	O
,	O
play	O
a	O
role	O
in	O
increased	O
level	O
of	O
circulating	O
immune	O
complexes	I:C0003313
with	O
occurrence	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
heat	O
shock	I:C0018850
proteins	I:C0018850
in	O
patients	O
with	O
sarcoidosis	B:C0036202
.	O

However	O
,	O
this	O
immunocomplexemia	B:C0037088
might	O
also	O
be	O
caused	O
by	O
decreased	O
clearance	O
by	O
immune	O
cells	I:C0007634
due	O
to	O
a	O
changed	O
copy	O
number	O
of	O
FCGR	O
genes	I:C0017337
.	O

However	O
,	O
this	O
immunocomplexemia	O
might	O
also	O
be	O
caused	O
by	O
decreased	O
clearance	O
by	O
immune	B:C0007634
cells	I:C0007634
due	O
to	O
a	O
changed	O
copy	O
number	O
of	O
FCGR	O
genes	I:C0017337
.	O

However	O
,	O
this	O
immunocomplexemia	O
might	O
also	O
be	O
caused	O
by	O
decreased	O
clearance	O
by	O
immune	O
cells	I:C0007634
due	O
to	O
a	O
changed	O
copy	O
number	O
of	O
FCGR	B:C0017337
genes	I:C0017337
.	O

Thus	O
,	O
the	O
next	O
step	O
of	O
our	O
study	O
was	O
to	O
evaluate	B:C0220825
copy	O
number	I:C1511518
variation	I:C1511518
of	O
FCGR2A	O
,	O
FCGR2B	O
,	O
FCGR2C	O
,	O
FCGR3A	O
and	O
FCGR3B	O
in	O
this	O
disease	O
.	O

Thus	O
,	O
the	O
next	O
step	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
copy	B:C1511518
number	I:C1511518
variation	I:C1511518
of	O
FCGR2A	O
,	O
FCGR2B	O
,	O
FCGR2C	O
,	O
FCGR3A	O
and	O
FCGR3B	O
in	O
this	O
disease	O
.	O

Thus	O
,	O
the	O
next	O
step	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
FCGR2A	B:C1414553
,	O
FCGR2B	O
,	O
FCGR2C	O
,	O
FCGR3A	O
and	O
FCGR3B	O
in	O
this	O
disease	O
.	O

Thus	O
,	O
the	O
next	O
step	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
FCGR2A	O
,	O
FCGR2B	B:C1414554
,	O
FCGR2C	O
,	O
FCGR3A	O
and	O
FCGR3B	O
in	O
this	O
disease	O
.	O

Thus	O
,	O
the	O
next	O
step	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
FCGR2A	O
,	O
FCGR2B	O
,	O
FCGR2C	B:C1521989
,	O
FCGR3A	O
and	O
FCGR3B	O
in	O
this	O
disease	O
.	O

Thus	O
,	O
the	O
next	O
step	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
FCGR2A	O
,	O
FCGR2B	O
,	O
FCGR2C	O
,	O
FCGR3A	B:C1414555
and	O
FCGR3B	O
in	O
this	O
disease	O
.	O

Thus	O
,	O
the	O
next	O
step	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
FCGR2A	O
,	O
FCGR2B	O
,	O
FCGR2C	O
,	O
FCGR3A	O
and	O
FCGR3B	B:C1414556
in	O
this	O
disease	O
.	O

Thus	O
,	O
the	O
next	O
step	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
FCGR2A	O
,	O
FCGR2B	O
,	O
FCGR2C	O
,	O
FCGR3A	O
and	O
FCGR3B	O
in	O
this	O
disease	B:C0012634
.	O

The	O
analysis	B:C0936012
was	O
carried	O
out	O
by	O
real	O
-	I:C3179034
time	I:C3179034
quantitative	I:C3179034
PCR	I:C3179034
on	O
104	O
patients	O
and	O
110	O
healthy	O
volunteers	I:C1708335
.	O

The	O
analysis	O
was	O
carried	O
out	O
by	O
real	B:C3179034
-	I:C3179034
time	I:C3179034
quantitative	I:C3179034
PCR	I:C3179034
on	O
104	O
patients	O
and	O
110	O
healthy	O
volunteers	I:C1708335
.	O

The	O
analysis	O
was	O
carried	O
out	O
by	O
real	O
-	I:C3179034
time	I:C3179034
quantitative	I:C3179034
PCR	I:C3179034
on	O
104	O
patients	O
and	O
110	O
healthy	B:C1708335
volunteers	I:C1708335
.	O

Despite	O
previously	O
detected	B:C0442726
variation	O
in	O
allele	O
/	O
genotype	O
frequencies	O
of	O
FCGR	O
in	O
sarcoidosis	O
and	O
its	O
particular	O
stages	O
,	O
there	O
was	O
no	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
the	O
tested	O
genes	O
between	O
sarcoidosis	O
or	O
its	O
stages	O
and	O
healthy	O
control	O
,	O
as	O
well	O
as	O
between	O
stages	O
themselves	O
.	O

Despite	O
previously	O
detected	O
variation	B:C1511518
in	O
allele	O
/	O
genotype	O
frequencies	O
of	O
FCGR	O
in	O
sarcoidosis	O
and	O
its	O
particular	O
stages	O
,	O
there	O
was	O
no	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
the	O
tested	O
genes	O
between	O
sarcoidosis	O
or	O
its	O
stages	O
and	O
healthy	O
control	O
,	O
as	O
well	O
as	O
between	O
stages	O
themselves	O
.	O

Despite	O
previously	O
detected	O
variation	O
in	O
allele	B:C0002085
/	O
genotype	O
frequencies	O
of	O
FCGR	O
in	O
sarcoidosis	O
and	O
its	O
particular	O
stages	O
,	O
there	O
was	O
no	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
the	O
tested	O
genes	O
between	O
sarcoidosis	O
or	O
its	O
stages	O
and	O
healthy	O
control	O
,	O
as	O
well	O
as	O
between	O
stages	O
themselves	O
.	O

Despite	O
previously	O
detected	O
variation	O
in	O
allele	O
/	O
genotype	O
frequencies	O
of	O
FCGR	B:C0017337
in	O
sarcoidosis	O
and	O
its	O
particular	O
stages	O
,	O
there	O
was	O
no	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
the	O
tested	O
genes	O
between	O
sarcoidosis	O
or	O
its	O
stages	O
and	O
healthy	O
control	O
,	O
as	O
well	O
as	O
between	O
stages	O
themselves	O
.	O

Despite	O
previously	O
detected	O
variation	O
in	O
allele	O
/	O
genotype	O
frequencies	O
of	O
FCGR	O
in	O
sarcoidosis	B:C0036202
and	O
its	O
particular	O
stages	O
,	O
there	O
was	O
no	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
the	O
tested	O
genes	O
between	O
sarcoidosis	O
or	O
its	O
stages	O
and	O
healthy	O
control	O
,	O
as	O
well	O
as	O
between	O
stages	O
themselves	O
.	O

Despite	O
previously	O
detected	O
variation	O
in	O
allele	O
/	O
genotype	O
frequencies	O
of	O
FCGR	O
in	O
sarcoidosis	O
and	O
its	O
particular	O
stages	O
,	O
there	O
was	O
no	O
copy	B:C1511518
number	I:C1511518
variation	I:C1511518
of	O
the	O
tested	O
genes	O
between	O
sarcoidosis	O
or	O
its	O
stages	O
and	O
healthy	O
control	O
,	O
as	O
well	O
as	O
between	O
stages	O
themselves	O
.	O

Despite	O
previously	O
detected	O
variation	O
in	O
allele	O
/	O
genotype	O
frequencies	O
of	O
FCGR	O
in	O
sarcoidosis	O
and	O
its	O
particular	O
stages	O
,	O
there	O
was	O
no	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
the	O
tested	O
genes	B:C0017337
between	O
sarcoidosis	O
or	O
its	O
stages	O
and	O
healthy	O
control	O
,	O
as	O
well	O
as	O
between	O
stages	O
themselves	O
.	O

Despite	O
previously	O
detected	O
variation	O
in	O
allele	O
/	O
genotype	O
frequencies	O
of	O
FCGR	O
in	O
sarcoidosis	O
and	O
its	O
particular	O
stages	O
,	O
there	O
was	O
no	O
copy	O
number	I:C1511518
variation	I:C1511518
of	O
the	O
tested	O
genes	O
between	O
sarcoidosis	B:C0036202
or	O
its	O
stages	O
and	O
healthy	O
control	O
,	O
as	O
well	O
as	O
between	O
stages	O
themselves	O
.	O

A	O
relevant	O
increase	O
in	O
copy	O
number	O
of	O
FCGR2C	B:C1521989
and	O
FCGR3B	O
in	O
Stage	O
IV	O
of	O
sarcoidosis	O
vs.	O
other	O
stages	O
and	O
controls	O
was	O
detected	O
,	O
but	O
this	O
observation	O
was	O
based	O
on	O
a	O
limited	O
number	O
of	O
Stage	O
IV	O
patients	O
.	O

A	O
relevant	O
increase	O
in	O
copy	O
number	O
of	O
FCGR2C	O
and	O
FCGR3B	B:C1414556
in	O
Stage	O
IV	O
of	O
sarcoidosis	O
vs.	O
other	O
stages	O
and	O
controls	O
was	O
detected	O
,	O
but	O
this	O
observation	O
was	O
based	O
on	O
a	O
limited	O
number	O
of	O
Stage	O
IV	O
patients	O
.	O

A	O
relevant	O
increase	O
in	O
copy	O
number	O
of	O
FCGR2C	O
and	O
FCGR3B	O
in	O
Stage	O
IV	O
of	O
sarcoidosis	B:C0036202
vs.	O
other	O
stages	O
and	O
controls	O
was	O
detected	O
,	O
but	O
this	O
observation	O
was	O
based	O
on	O
a	O
limited	O
number	O
of	O
Stage	O
IV	O
patients	O
.	O

A	O
relevant	O
increase	O
in	O
copy	O
number	O
of	O
FCGR2C	O
and	O
FCGR3B	O
in	O
Stage	O
IV	O
of	O
sarcoidosis	O
vs.	O
other	O
stages	O
and	O
controls	O
was	O
detected	B:C0442726
,	O
but	O
this	O
observation	O
was	O
based	O
on	O
a	O
limited	O
number	O
of	O
Stage	O
IV	O
patients	O
.	O

A	O
relevant	O
increase	O
in	O
copy	O
number	O
of	O
FCGR2C	O
and	O
FCGR3B	O
in	O
Stage	O
IV	O
of	O
sarcoidosis	O
vs.	O
other	O
stages	O
and	O
controls	O
was	O
detected	O
,	O
but	O
this	O
observation	B:C0302523
was	O
based	O
on	O
a	O
limited	O
number	O
of	O
Stage	O
IV	O
patients	O
.	O

Hence	O
,	O
polymorphism	O
of	O
FCGR	B:C0017337
genes	I:C0017337
seems	O
to	O
be	O
more	O
important	O
than	O
their	O
copy	O
number	I:C1511518
variation	I:C1511518
in	O
etiopathogenesis	O
of	O
sarcoidosis	O
in	O
patients	O
from	O
the	O
Polish	O
population	I:C0220896
.	O

Hence	O
,	O
polymorphism	O
of	O
FCGR	O
genes	I:C0017337
seems	O
to	O
be	O
more	O
important	O
than	O
their	O
copy	B:C1511518
number	I:C1511518
variation	I:C1511518
in	O
etiopathogenesis	O
of	O
sarcoidosis	O
in	O
patients	O
from	O
the	O
Polish	O
population	I:C0220896
.	O

Hence	O
,	O
polymorphism	O
of	O
FCGR	O
genes	I:C0017337
seems	O
to	O
be	O
more	O
important	O
than	O
their	O
copy	O
number	I:C1511518
variation	I:C1511518
in	O
etiopathogenesis	O
of	O
sarcoidosis	B:C0036202
in	O
patients	O
from	O
the	O
Polish	O
population	I:C0220896
.	O

Hence	O
,	O
polymorphism	O
of	O
FCGR	O
genes	I:C0017337
seems	O
to	O
be	O
more	O
important	O
than	O
their	O
copy	O
number	I:C1511518
variation	I:C1511518
in	O
etiopathogenesis	O
of	O
sarcoidosis	O
in	O
patients	O
from	O
the	O
Polish	B:C0220896
population	I:C0220896
.	O

